9 -Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain

By Burkey T.H.   Quock R.M.   Consroe P.   Roeske W.R.   Yamamura H.I.  

European Journal of Pharmacology, Vol. 323, Iss. 2, 1997-04 ,pp. : 3-4

Elsevier

Access to resources Recommend Favorite

Relative involvement of cannabinoid CB 1 and CB 2 receptors in the 9 -tetrahydrocannabinol-induced inhibition of natural killer activity

By Massi P.   Fuzio D.   Vigano D.   Sacerdote P.   Parolaro D.  

European Journal of Pharmacology, Vol. 387, Iss. 3, 2000-01 ,pp. : 343-347

Elsevier

Access to resources Recommend Favorite

9 -Tetrahydrocannabinol inhibits gastric motility in the rat through cannabinoid CB 1 receptors

By Krowicki Z.K.   Moerschbaecher J.M.   Winsauer P.J.   Digavalli S.V.   Hornby P.J.  

European Journal of Pharmacology, Vol. 371, Iss. 2, 1999-04 ,pp. : 187-196

Elsevier

Access to resources Recommend Favorite

Effects of the cannabinoid CB 1 receptor antagonist, SR141716A, after 9 -tetrahydrocannabinol withdrawal

By Beardsley P.M.   Martin B.R.  

European Journal of Pharmacology, Vol. 387, Iss. 1, 2000-11 ,pp. : 47-53

Elsevier

Access to resources Recommend Favorite

Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine

By Robson Philip  

Expert Opinion on Drug Safety, Vol. 10, Iss. 5, 2011-09 ,pp. : 675-685

Informa Healthcare

Access to resources Recommend Favorite